ReddRadar
What is Linguamatics?
Linguamatics is a leading provider of AI-enabled language and translation solutions specifically designed for the healthcare and life sciences industry. The platform combines Natural Language Processing (NLP), Neural Machine Translation (NMT), and specialized linguistic expertise to help organizations manage their global operations more efficiently.
The company's comprehensive suite of solutions includes translation management (hub), instant translation capabilities (translate), and advanced AI text analysis tools. With over 20 years of healthcare AI expertise, Linguamatics delivers industry-leading accuracy scores and supports operations across 150+ languages through its user-friendly portal and integration options.
Features
- Healthcare-Specific NLP: Proprietary technology with 95+ F-score for healthcare applications
- Multi-language Support: Access to 150+ languages through user-friendly portal
- Secure Translation: Protected and compliant data handling for sensitive information
- Integration Capabilities: Seamless workflow integration options
- Specialized Expertise: 20+ years of healthcare AI experience
- Clinical Trial Support: Extensive experience in global clinical trials
Use Cases
- Clinical research and operations
- Regulatory affairs management
- Medical affairs and HEOR
- Safety and pharmacovigilance
- Brand and HCP engagement
- Patient access and engagement
- Global compliance optimization
- Clinical trial translation
- Target discovery acceleration
FAQs
-
How many languages does Linguamatics support?
Linguamatics supports more than 150 languages through its user-friendly portal with full integration potential. -
What is the accuracy rate of Linguamatics' NLP technology?
Linguamatics' Natural Language Processing technology achieves a 95+ F-score, recognized as the best AI technology for healthcare in the 2023 AI breakthrough awards. -
How many clinical trials has Linguamatics supported?
In 2022, Linguamatics supported over 700 global clinical trials, establishing itself as the leading solution for enabling trials at scale.
